Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Trusted Resources

  • Education
  • Videos & Visuals
  1. Home
  2. Trusted Resources
Tips on Caring for a Loved One With hATTR Amyloidosis
Read more
Tips for Living Your Best Life With hATTR Amyloidosis
Read more
Tips for Managing Your Professional Life With hATTR Amyloidosis
Read more
Amyloidosis & Kidney Disease
Read more
Talking With Your Doctor About hATTR Amyloidosis
Read more
How to Talk With Your Family About Your hATTR Amyloidosis Diagnosis?
Read more
Diarrhea and AL Amyloidosis
Read more
The SAP Scan - AL Amyloidosis
Read more
AL Amyloidosis and the Kidney
Read more
Steroids for AL Amyloidosis
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.
Image
Featured CT
external link, opens in a new tab

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login

© 2025 Somebody To Talk To, Inc.

Join us on